Phase II Study of ASP3550 in Patients With Prostate Cancer
NCT00568516
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
273
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Neoplasms
Interventions
DRUG:
ASP3550
Sponsor
Astellas Pharma Inc